Cost Effectiveness for Stage I Lung Cancer Therapies

Researchers found that the more cost-effective option (surgery vs SBRT) in stage I lung cancer depends on whether the disease is clearly or marginally operable.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news